nach oben

Acta Diabetologica

Erschienen in:

01.06.2013 | Original Article

Lipid accumulation in overweight type 2 diabetic subjects: relationships with insulin sensitivity and adipokines

verfasst von: Maria Sambataro, Gianluca Perseghin, Guido Lattuada, Giampietro Beltramello, Livio Luzi, Giovanni Pacini

Erschienen in: Acta Diabetologica | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Adipokines are known to play a fundamental role in the etiology of obesity, that is, in the impaired balance between increased feeding and decreased energy expenditure. While the adipokine-induced changes of insulin resistance in obese diabetic and nondiabetic subjects are well known, the possible role of fat source in modulating insulin sensitivity (IS) remains controversial. The aim of our study was to explore in overweight type 2 diabetic patients (T2DM) with metabolic syndrome IS in different energy storage conditions (basal and dynamic) for relating it to leptin and adiponectin. Sixteen T2DM (5/11 F/M; 59 ± 2 years; 29.5 ± 1.1 kg/m²) and 16 control (CNT 5/11; 54 ± 2; 29.1 ± 1.0) underwent an oral glucose tolerance test. Fasting IS was measured by QUICKI, while the dynamic one with OGIS. The insulinogenic index (IGI) described beta cell function. Also, the lipid accumulation product parameter (LAP) was assessed. LAP accounts for visceral abdominal fat and triglycerides, and it is known to be related to IS. Possible interrelationships between LAP and adipokines were explored. In T2DM and CNT, adiponectin (7.4 ± 0.5 vs. 7.8 ± 0.9 μg/mL), leptin (13.3 ± 3.0 vs. 12.4 ± 2.6 ng/mL), and QUICKI (0.33 ± 0.01 vs. 0.33 ± 0.01) were not different (P > 0.40), at variance with OGIS (317 ± 11 vs. 406 ± 13 mL/min/m²; P = 0.006) and IGI (0.029 ± 0.005 vs. 0.185 ± 0.029 × 10³ pmol_I/mmol_G; P = 0.00001). LAP was 85 ± 15 cm × mg/dL in T2DM and 74 ± 10 in CNT (P > 0.1), correlated with OGIS in all subjects (R = −0.42, P = 0.02) and QUICKI (R = −0.56, P = 0.025) in T2DM. Leptin correlated with QUICKI (R = −0.45, P = 0.009), and adiponectin correlated with OGIS (R = 0.43, P = 0.015). In overweight T2DM, insulin sensitivity in basal condition appears to be multifaceted with respect to the dynamic one, because it should be more fat-related. Insulin sensitivity appears to be incompletely described by functions of fasting glucose and insulin values alone and the use of other indices, such as LAP could be suggested.

Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37:1595–1607PubMedCrossRef

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2001) Executive summary of the third report of the national cholesterol in adults (NCEP). JAMA 285:2486–2497

Alberti KG, Zimmet P, Shaw J for IDF Epidemiology Task Force Consensus Group (2005) The metabolic syndrome: a new worldwide definition. Lancet 366:1059–1062

Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association. Circulation 109:433–438PubMedCrossRef

Grundy SM, Cleeman JI, Daniels SR (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112:2735–2752PubMedCrossRef

Khan R, Buse J, Ferrannini E, Stem M (2005) The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28:2289–2304CrossRef

Petersen KF, Dufour S, Savage DB, Bilz S, Solomon G, Yonemitsu S, Cline GW, Befroy D, Zemany L, Kahn BB, Papademetris X, Rothman DL, Shulman GI (2007) The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci USA 31:12587–12594CrossRef

McAteer JB, Prudente S, Bacci S, Lyon HN, Hirschhom JN, Trischitta V, Florez JC for the ENPP1 Consortium (2008) The ENPP1 K121Q polymorphism is associated with T2DM in European population. Diabetes 57:1125–1130

Dyck DJ, Heigenhauser GJF, Bruce CR (2006) The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol 186:5–16CrossRef

10.

Yudkin JS (2005) Vasocrine signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 365:1817–1830PubMedCrossRef

11.

Shimizu H, Inoue K, Mori M (2007) The leptin-dependent and-independent melanocortin signaling system regulation of feeding and energy expenditure. J Endocrinol 193:1–9PubMedCrossRef

12.

Arner P (2005) Insulin resistance in type 2 diabetes—role of adipokines. Curr Mol Med 5:333–339PubMedCrossRef

13.

Shuldiner AR, Yang R, Gong DW (2001) Resistin, obesity, and insulin resistance—the emerging role of the adipocyte as an endocrine organ. N Engl J Med 345:1345–1346PubMedCrossRef

14.

Silha JV, Krsek M, Skrha MJV, Sucharda P, Nyomba GLG, Murphy LJ (2003) Plasma resistin, adiponectin and leptin level in lean and obese subjects. Correlation with insulin resistance. Eur J Endocrinol 149:331–335PubMedCrossRef

15.

Perseghin G, Lattuada G, De Cobelli F, Esposito A, Belloni E, Canu T, Ragogna F, Scifo P, Del Maschio A, Luzi L (2007) Serum retinol-binding-4 leptin, and adiponectin concentrations are related to ectopic fat accumulation. J Clin Endocrinol Metab 92:4883–4888PubMedCrossRef

16.

Rabe K, Lehrke M, Parhofer KG, Broedl UC (2008) Adipokines and insulin resistance. Mol Med 14:741–751PubMedCrossRef

17.

Hroussalas G, Kassi E, Dalamaga M, Delimaris I, Zachari A, Dionyssiou-Asteriou A (2008) Leptin, soluble leptin receptor, adiponectin and resistin in relation to OGTT in overweight/obese postmenopausal women. Maturitas 59:339–349PubMedCrossRef

18.

Kahn SH (2005) The “lipid accumulation product’’ performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord 5:26PubMedCrossRef

19.

Kahn SH (2006) The lipid accumulation product is better than the body mass index for identifying diabetes. Diabetes Care 29:151–153PubMedCrossRef

20.

Stein A, Myers GL (1994) Tietz textbook of clinical chemistry, 2nd edn. Saunders, New York

21.

Perseghin G (2006) Serum resistin and hepatic fat content in nondiabetic individuals. J Clin Endocrinol Metab 91:5122–5125PubMedCrossRef

22.

Perseghin G (2001) Gender factors affect fatty acids-induced insulin resistance in nonobese humans: effects of oral steroidal contraception. J Clin Endocrinol Metab 86:3188–3196PubMedCrossRef

23.

Koenig W, Sund M, Fröhlich M, Fischer HG, Lo H, Doring A, Hutchinson WL, Pepys MB for MONICA-Augsburg Cohort Study (1999). CRP, a sensitive marker for inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation 99:237–42

24.

Balkau B, Deanfield JE, Despres JP, Bassand GP, Fox AAK, Smith SC Jr, Tan CE, Van Gal L, Wittchen HU, Massien C, Haffner SM (2007) International day for the evaluation of abdominal obesity (IDEA) study of waist circumference, cardiovascular disease, and diabetes mellitus in 168000 primary care patients in 63 countries. Circulation 116:1942–1951PubMedCrossRef

25.

Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402–2410PubMedCrossRef

26.

Abdul-Ghani MA, Matsuda M, Balas B, De Fronzo RA (2007) Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30:89–94PubMedCrossRef

27.

Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539–548PubMedCrossRef

28.

Sambataro M, Maioli M, Tonolo G, Stenhower CDA, van Hinsbergh VWM, Piarulli F, Nosadini R, Pacini G (2002) Insulin sensitivity correlates with glycogen synthesis rate, but not with von Willebrand factor in type 2 diabetes. Eur J Int Med 13:439–444CrossRef

29.

Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, De Fronzo RA (2006) Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance. Diabetes 55:1430–1435PubMedCrossRef

30.

Abdul–Ghani MA, Tripathy D, De Fronzo RA (2006) Contributions of cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29:1130–1139PubMedCrossRef

31.

Abdul-Ghani MA, Matsuda M, DeFronzo RA (2008) Strong association between insulin resistance in liver and skeletal muscle in non-diabetic subjects. Diabet Med 25:1289–1294PubMed

32.

Tura A, Kautzky-Willer A, Pacini G (2006) Insulinogenic indices from insulin, C-peptide: comparison of beta-cell function from OGTT, IVGTT. Diabetes Res Clin Pract 72:298–301PubMedCrossRef

33.

de Piano A, Tock L, Carnier J, Oyama LM, Oller do Nascimento CM, Martinz AC, Foschini D, Sanches PL, Ernandes RM, de Mello MT, Tufik S, Dâmaso AR (2010) Negative correlation between neuropeptide Y/agouti-related protein concentration and adiponectinemia in nonalcoholic fatty liver disease obese adolescents submitted to a long-term interdisciplinary therapy. Metabolism 59:613–619PubMedCrossRef

34.

Meyer C, Pimenta W, Woerle HJ, Van Haeften T, Szoke E, Mitrakou A, Gerich J (2006) Different mechanism for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 29:1909–1914PubMedCrossRef

35.

Snijder MB, Dekker MJ, Visser M, Bouter LM, Stehouwer CD, Yudkin JS, Heine RJ, Nijpels G, Seidell JC (2004) Hoorn study. Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels. Diabetes Care 27:372–377PubMedCrossRef

36.

Snijder MB, Flyvbjerg A, Stehouwer CDA, Frystyk J, Henry RM, Seidell JC, Heine RJ, Dekker JM (2009) Relationship of adiposity with arterial stiffness as mediated by adiponectin in older man and women: the Hoorn Study. Eur J Endocrinol 160:87–95

37.

Finucane FM, Luan J, Wareham NJ, Sharp SJ, O’Rahilly S, Balkau B, Flyvbjerg A, Walker M, Højlund K, Nolan JJ, Savage DB (2009) Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia 52:2345–2349PubMedCrossRef

38.

Inoue M, Maehata E, Yano-Mtaniyama M, Suzuki S (2005) Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type two diabetes. Metabolism 54:281–286PubMedCrossRef

39.

Avogaro A, Sambataro M, Marangoni A, Pianta A, Vettor R, Pagano C, Marescotti MC, Tiengo A, Beltramello G (2003) Moderate alcohol consumption, glucose metabolism and lipolysis: the effect on adiponectin and tumor necrosis factor alpha. J Endocrinol Invest 26:1213–1218PubMed

40.

Giorgino F, Laviola L, Eriksson JW (2005) Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies. Acta Physiol Scand 183:13–30PubMedCrossRef

41.

Giorgino F, Laviola L, Leonardini A (2005) Pathophysiology of T2DM: rationale for different oral antidiabetic treatment strategies. Diabetes Res Clin Pract 68:S22–S29PubMedCrossRef

Titel: Lipid accumulation in overweight type 2 diabetic subjects: relationships with insulin sensitivity and adipokines
verfasst von: Maria Sambataro
Gianluca Perseghin
Guido Lattuada
Giampietro Beltramello
Livio Luzi
Giovanni Pacini
Publikationsdatum: 01.06.2013
Verlag: Springer Milan
Erschienen in: Acta Diabetologica / Ausgabe 3/2013
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-011-0366-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2013

Polymorphisms in the Selenoprotein S gene and subclinical cardiovascular disease in the Diabetes Heart Study

Body composition changes and cardiometabolic benefits of a balanced Italian Mediterranean Diet in obese patients with metabolic syndrome

Achieving glycemic control in patients with type 2 diabetes and renal impairment

PPARG2 Pro12Ala and ADAMTS9 rs4607103 as “insulin resistance loci” and “insulin secretion loci” in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4

Exercise might improve cardiovascular autonomic regulation in adolescents with type 1 diabetes